
Takeda has acquired Maverick Therapeutics in a deal worth up to $525 million, in order to expand its portfolio of …

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

